Sridhara Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 7.70 M
as on 17-07-2024
- Company Age 8 Year, 20 Days
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 4.00 Cr
as on 17-07-2024
- Revenue -97.67%
(FY 2021)
- Profit -3927.33%
(FY 2021)
- Ebitda -169.51%
(FY 2021)
- Net Worth -79.87%
(FY 2021)
- Total Assets -17.16%
(FY 2021)
About Sridhara Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.70 M.
The company currently has active open charges totaling ₹4.00 Cr.
The Key Managerial Personnel (KMP) at Sridhara Life Sciences Private Limited India is Roop Chowhan as CEO. Abhijeet Chauhan, Narendra Tomar, and Ravindra Rathore serve as directors at the Company.
- CIN/LLPIN
U52609MP2016PTC041961
- Company No.
041961
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2016
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sridhara Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Roop Chowhan  | CEO | 06-Dec-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhijeet Chauhan | Director | 08-Dec-2016 | Current |
| Narendra Tomar | Director | Current | |
| Ravindra Rathore | Director | 29-Aug-2019 | Current |
Financial Performance of Sridhara Life Sciences.
Sridhara Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 97.67% decrease. The company also saw a substantial fall in profitability, with a 3927.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 79.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sridhara Life Sciences?
In 2021, Sridhara Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Nvst Nirman Consultants Private LimitedInactive For E-Filing 8 months 7 days
Narendra Tomar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 16 Feb 2019 | ₹4.00 Cr | Open |
How Many Employees Work at Sridhara Life Sciences?
Sridhara Life Sciences has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sridhara Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sridhara Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
